FinArc Investments’s Amgen AMGN Stock Holding History

FinArc Investments’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69M	Buy	10,194 +44	+0.4%	+$15.1K	3.35%	7
2026 Q1	$3.57M	Buy	+10,150	New	+$3.62M	3.44%	7

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FinArc Investments's AMGN Position: Q2 2026 in Review

FinArc Investments increased its Amgen (AMGN) stake by 0.43% in Q2 2026, buying an estimated $15.1K and bringing the position to 10,194 shares worth $3.69M. The position accounts for 3.35% of the portfolio, ranked #7.

FinArc Investments first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

FinArc Investments held 10,194 shares of Amgen worth $3.69M as of Q2 2026.
FinArc Investments bought 44 Amgen shares in Q2 2026, an estimated $15.1K.
Amgen made up 3.35% of FinArc Investments's portfolio in Q2 2026, its #7 holding.
FinArc Investments first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on FinArc Investments's 13F filing for Q2 2026, filed 13 Aug 2026.